News

Diet, exercise improved peak oxygen intake in obese HFpEF patients

View on the News

Better than medication?

Because this study of increased exercise capacity in persons who have heart failure with preserved ejection fraction focuses on the changes in symptoms, rather than the cardiac output, the results are paradigm shifting. That’s exciting for our older populations because we want to avoid medications and because exercise is so important in older adults for so many reasons, including self-confidence, stability, and function.

Dr. Susan Zieman

In the past, most of the drugs used in heart failure targeted either volume or pace. But diuretics to lessen volume and beta-blockers or calcium-channel blockers to slow the heart haven’t really helped HFpEF patients a great deal.

I always keep in the back of my mind that no drug is better than any drug, particularly in our older populations that are more vulnerable to side effects.

Although clinicians should not necessarily advise HFpEF patients to begin a diet and exercise regime just yet, the study points toward these interventions as being safe and effective. We still need more data on the study participants who were on diet and exercise and lost muscle mass.

I expect Dr. Kitzman’s current investigation into resistance training in HFpEF to elucidate just how much diet, aerobic exercise, and strength can improve outcomes.

“I think all could easily be added to the treatment regimen. It might actually be that these interventions will prove better than medications,” Dr. Zieman said.

Dr. Susan Zieman, medical officer, National Institute on Aging, Division of Geriatrics and Clinical Gerontology, made these remarks in an interview.


 

FROM JAMA

References

Because higher levels of adipose tissue are associated with inflammation, hypertension, insulin resistance, and dyslipidemia, the study authors theorized that, as the body mass ratios of study participants improved, their bodies became more efficient at extracting oxygen from the blood, and thus could better sustain physical activity.

Although there were few adverse events observed in the study, including acute shortness of breath in a member of the exercise-only group, Dr. Kitzman said in a JAMA podcast that, of some concern was that a third of the body mass lost by participants was muscle tissue. “That’s important because persons with heart failure have less-than-normal amounts of muscle tissue as part of their heart failure syndrome and as part of growing old. It could have adverse long-term consequences,” he said.

Dr. Kitzman said in an interview that he and his colleagues have decided next to focus on resistance training’s impact on VO2, after this study showed that overall muscle mass decreased mildly with diet, even with aerobic exercise. The new study will seek to establish a correlation between improved retention of skeletal muscle, strength, and overall function and resistance training combined with diet and aerobic exercise in HFpEF.

“We chose resistance training because it is known to increase skeletal muscle mass. On the other hand, resistance training can temporarily increase blood pressure and left ventricular afterload, which are already increased in HFpEF,” he said.

The net effect is that, at least for now, “resistance training in HFpEF should be formally tested before applying to patients,” Dr. Kitzman noted. The same is true, he added, for recommending dietary restrictions in HFpEF patients.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Pages

Recommended Reading

AHA: HFpEF, HFrEF cause similar acute hospitalization rates
MDedge Family Medicine
AHA: Empagliflozin for T2D reduces heart failure endpoints
MDedge Family Medicine
AHA: Spirometry identifies mortality risk in asymptomatic adults
MDedge Family Medicine
AHA: Three measures risk stratify acute heart failure
MDedge Family Medicine
AHA: Should BP targets be higher in asymptomatic aortic stenosis?
MDedge Family Medicine
VIDEO: Beta-blocker prevented trastuzumab-related drop in LVEF
MDedge Family Medicine
FDA cancels REMS for rosiglitazone
MDedge Family Medicine
Beta-blocker prevents trastuzumab-related LVEF drop
MDedge Family Medicine
Chagas disease: Neither foreign nor untreatable
MDedge Family Medicine
The palliative path: Talking with elderly patients facing emergency surgery
MDedge Family Medicine